Trials / Completed
CompletedNCT04274660
Evaluation of Diabetes and WELLbeing Programme
Evaluation of the Diabetes and WELLbeing (DWELL) Programme for People With Type 2 Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 594 (actual)
- Sponsor
- Canterbury Christ Church University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the impact of 'DWELL' - a 12-week psycho-social education programme designed to help people with type 2 diabetes to better self-manage their condition. Up to 600 patients will participate in the programme, while a non-intervention group will receive routine care for their diabetes
Detailed description
The DWELL (Diabetes and WELLbeing) 12-week programme has been designed to incorporate specific elements of diabetes education and is underpinned by motivational interviewing to ensure it is tailored to individuals. Each of the four elements of the programme - education, nutrition, physical activity and wellbeing - have been carefully selected based on previous research into diabetes education. The Canterbury Christ Church University (CCCU) DWELL Team are responsible for the evaluation of DWELL, which will explore whether the combination of the programme elements is effective in improving self-management. Additionally, a process evaluation and cost effectiveness analysis will be conducted alongside participant outcomes The programme will be delivered at five sites (two in the UK, one in Belgium, one in France, one in the Netherlands). The CCCU DWELL research team will be responsible for quality assurance, management and analysis of data, sample size assessment and reporting of adverse events. Each delivery site is responsible for adhering to their own Standard Operating Procedures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | DWELL (Diabetes and WELLbeing) Programme | 12-week psychoeducational programme |
Timeline
- Start date
- 2017-09-08
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2020-02-18
- Last updated
- 2024-02-14
Locations
5 sites across 4 countries: Belgium, France, Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT04274660. Inclusion in this directory is not an endorsement.